Biovotion was honoured with a prestigious eHealth EU SME competition award, at the eHealth week 2013 in Dublin, Ireland. Over the last six months, ten companies were selected, from more than 200 registrants, to enter the final of the EU SME eHealth competition. Biovotion was awarded the silver medal for the development of its VSM platform.
The awardees were selected by an international panel of eHealth experts, venture capital investors and industrial representatives, during the biggest European eHealth conference, bringing together more than 3000 international attendees from industry, healthcare, academia and politics, with the participation of major European political leaders.
"The team at Biovotion has been working very hard in the last few years to achieve the product level now regarded as being amongst the European leaders as a new player in the field of mHealth", says Andreas Caduff, CEO and Co-Founder of the company. "We are very pleased with this distinction, taking it as a further motivation to continue our path towards the market ".
The Vital Sign Monitor (VSM) is a wearable multi-sensor platform for continuous, non-invasive monitoring of physiological parameters. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing and transmission into cloud storage. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters. It has been demonstrated that the VSM platform provides vital sign data quality on par with standard hospital devices.
With “consumerised healthcare” rapidly advancing and the medical device space seeing a transition towards patient home monitoring concepts, Biovotion sees its expertise and product development as instrumental in delivering solutions to this unfolding market.
Together with the continuing increase in healthcare costs, growing numbers of chronically ill patients or the number of elderly people that wish to pursue an independent life style, adequate monitoring is becoming key to tackle these challenges. With the VSM platform showing parity with standard hospital based systems today, Biovotion sees itself well positioned to provide such key elements.
Such a transition in healthcare has not only become an industry driven process but particularly has been recognised on a political and policy makers level globally, placing this topic as a top priority on the agenda of many decision makers. This was also acknowledged by both Neelie Kroes, European Commission Vice-President for the digital agenda as well as Tonio Borg, European Commissioner for Health and Consumer Affairs in their key note speeches.
Please login or sign up to comment.
Commenting guidelines